These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 9781924)
41. Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. Nietlispach F; Julius B; Schindler R; Bernheim A; Binkert C; Kiowski W; Brunner-La Rocca HP Hypertension; 2007 Jul; 50(1):82-8. PubMed ID: 17502494 [TBL] [Abstract][Full Text] [Related]
42. Nitric oxide plays an insignificant role in direct vasodilator effects of calcium channel blockers in healthy humans. Nakamura M; Arakawa N; Yoshida H; Naganuma Y; Nagano M; Hiramori K Heart Vessels; 2002 Mar; 16(3):105-10. PubMed ID: 12027232 [TBL] [Abstract][Full Text] [Related]
43. Impairment of the nitric oxide-mediated vasodilator response to mental stress in hypertensive but not in hypercholesterolemic patients. Cardillo C; Kilcoyne CM; Cannon RO; Panza JA J Am Coll Cardiol; 1998 Nov; 32(5):1207-13. PubMed ID: 9809927 [TBL] [Abstract][Full Text] [Related]
44. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors. Katz SD; Schwarz M; Yuen J; LeJemtel TH Circulation; 1993 Jul; 88(1):55-61. PubMed ID: 8391403 [TBL] [Abstract][Full Text] [Related]
45. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Perticone F; Ceravolo R; Maio R; Cloro C; Candigliota M; Scozzafava A; Mongiardo A; Mastroroberto P; Chello M; Mattioli PL Atherosclerosis; 2000 Oct; 152(2):511-8. PubMed ID: 10998481 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia. Cheriyan J; Webb AJ; Sarov-Blat L; Elkhawad M; Wallace SM; Mäki-Petäjä KM; Collier DJ; Morgan J; Fang Z; Willette RN; Lepore JJ; Cockcroft JR; Sprecher DL; Wilkinson IB Circulation; 2011 Feb; 123(5):515-23. PubMed ID: 21262998 [TBL] [Abstract][Full Text] [Related]
47. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871 [TBL] [Abstract][Full Text] [Related]
48. The contribution of nitric oxide to exercise hyperemia in the human forearm. Gordon MB; Jain R; Beckman JA; Creager MA Vasc Med; 2002 Aug; 7(3):163-8. PubMed ID: 12553738 [TBL] [Abstract][Full Text] [Related]
50. Serum nitrite sensitively reflects endothelial NO formation in human forearm vasculature: evidence for biochemical assessment of the endothelial L-arginine-NO pathway. Kelm M; Preik-Steinhoff H; Preik M; Strauer BE Cardiovasc Res; 1999 Mar; 41(3):765-72. PubMed ID: 10435049 [TBL] [Abstract][Full Text] [Related]
51. Bimodal distribution of vasodilator responsiveness to adenosine due to difference in nitric oxide contribution: implications for exercise hyperemia. Martin EA; Nicholson WT; Eisenach JH; Charkoudian N; Joyner MJ J Appl Physiol (1985); 2006 Aug; 101(2):492-9. PubMed ID: 16614358 [TBL] [Abstract][Full Text] [Related]
53. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor. Bruning TA; Chang PC; Blauw GJ; Vermeij P; van Zwieten PA J Cardiovasc Pharmacol; 1993 Jul; 22(1):44-51. PubMed ID: 7690095 [TBL] [Abstract][Full Text] [Related]
54. Vasodilator responses in the forearm skin of patients with insulin-dependent diabetes mellitus. Khan F; Cohen RA; Ruderman NB; Chipkin SR; Coffman JD Vasc Med; 1996; 1(3):187-93. PubMed ID: 9546937 [TBL] [Abstract][Full Text] [Related]
55. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients. Taddei S; Ghiadoni L; Virdis A; Buralli S; Salvetti A Circulation; 1999 Sep; 100(13):1400-5. PubMed ID: 10500040 [TBL] [Abstract][Full Text] [Related]
56. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Farquharson CA; Struthers AD Circulation; 2000 Feb; 101(6):594-7. PubMed ID: 10673249 [TBL] [Abstract][Full Text] [Related]
57. Studies with iontophoretic administration of drugs to human dermal vessels in vivo: cholinergic vasodilatation is mediated by dilator prostanoids rather than nitric oxide. Noon JP; Walker BR; Hand MF; Webb DJ Br J Clin Pharmacol; 1998 Jun; 45(6):545-50. PubMed ID: 9663809 [TBL] [Abstract][Full Text] [Related]
58. Effects of nitric oxide inhibition on basal forearm blood flow in patients with nonischemic chronic heart failure. Yoshida H; Nakamura M; Akatsu T; Arakawa N; Hiramori K Heart Vessels; 1998; 13(3):142-6. PubMed ID: 10328184 [TBL] [Abstract][Full Text] [Related]
59. Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Panza JA; García CE; Kilcoyne CM; Quyyumi AA; Cannon RO Circulation; 1995 Mar; 91(6):1732-8. PubMed ID: 7882481 [TBL] [Abstract][Full Text] [Related]
60. Insufficient sleep is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation. Bain AR; Weil BR; Diehl KJ; Greiner JJ; Stauffer BL; DeSouza CA Atherosclerosis; 2017 Oct; 265():41-46. PubMed ID: 28846879 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]